Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 275 participants.

Also called NCT06765356

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 275 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06765356
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06765356. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-15 (actual); primary completion 2027-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
Acronym
PROSPECT
Condition
Persistent Atrial Fibrillation
Condition
Paroxysmal Atrial Fibrillation
Condition
Long-standing Persistent Atrial Fibrillation
Intervention (Device)
Farapulse Catheter System
Intervention (Drug)
Low-dose Colchicine
Lead sponsor
Vivek Reddy (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct06765356
Content hash
ad203c13fdc711639277fdead3b454853d93d37d71b79ce81121db5c7d4a6fc2